Day: May 7, 2026

Market UpdatesSingapore SGX stocks

Global Market Rally as US-Iran Deal Nears, AI Stocks Surge, and Jiangxi Copper Upgrades Outlook – May 2026 Market Update 1

Minichart

May 7, 2026

Broker: OCBC Global Markets Date of Report: 7 May 2026 Excer...

Continue Reading 0

Market UpdatesSingapore SGX stocks

Frencken Group 2026 Outlook: Strong 2H26 Semiconductor Recovery Drives Higher Target Price | Maybank Research Analysis

Minichart

May 7, 2026

Broker: Maybank Research Pte Ltd Date of Report: May 6, 2026...

Continue Reading 0

Market UpdatesSingapore SGX stocks

Kimly Ltd Stock Analysis: Defensive F&B Growth, Consolidation Upside & Stable Dividends (2026 Outlook)

Minichart

May 7, 2026

Broker: DBS Group Research Date of Report: 07 May 2026 Exce...

Continue Reading 0

Bursa KLSE stocksHong Kong stocksMarket UpdatesREITS SGSingapore SGX stocks

Regional REITs Rebound in April 2026: Key Insights on Singapore, Hong Kong & Thai Markets, Yields, and Outlook

Minichart

May 7, 2026

Broker: DBS Group Research Date of Report: 7 May 2026 Excer...

Continue Reading 0

Market Updates

Global Markets Rally on US-Iran Peace Hopes, AI and Tech Stocks Surge, Top Equity Picks & Market Insights – May 2026 1

Minichart

May 7, 2026

Broker: OCBC Group Research Date of Report: 7 May 2026 Exc...

Continue Reading 0

Market UpdatesSingapore SGX stocks

Coliwoo Holdings (SGX: COLIWOO) 2026 Outlook: Strong 2H Growth, Asset-Light Expansion, and Buy Rating by Maybank Research

Minichart

May 7, 2026

Excerpt from Maybank Research Pte Ltd report. Report Summa...

Continue Reading 0

Market UpdatesSingapore SGX stocks

Frencken Group 2026 Outlook: Strong 2H26 Semiconductor Ramp-Up, Higher Price Target, and ESG Insights

Minichart

May 7, 2026

Broker: Maybank Research Pte Ltd Date of Report: May 6, 2026...

Continue Reading 0

Hong Kong Corporate News

Cutia Therapeutics’ CU-30101 Lidocaine and Tetracaine Cream Receives NMPA Drug Marketing Authorization in China 1

Minichart

May 7, 2026

Cutia Therapeutics Announcement: CU-30101 NMPA Approval ...

Continue Reading 0

Hong Kong Corporate News

Sino Biopharmaceutical Enrolls First Patient in Phase III Trial of Cafelkibart (CCR8 Monoclonal Antibody) for Second-Line Gastric Cancer Treatment

Minichart

May 7, 2026

Sino Biopharmaceutical: Major Clinical Milestone for Cafelki...

Continue Reading 0

Hong Kong Corporate News

Mabwell (Shanghai) Bioscience Announces 2026 EGM for Approval of RMB1 Billion Debt Financing Instrument

Minichart

May 7, 2026

Mabwell (Shanghai) Bioscience Co., Ltd. Announces 2026 Secon...

Continue Reading 0